Tetanus Antitoxin is indicated for the treatment of tetanus infection. It is used in individuals who have not received adequate tetanus immunization or those who have uncertain or incomplete immunization status and are at risk of developing tetanus.

Tetanus

• The dosage and administration of Tetanus Antitoxin may vary depending on the severity of the infection and the individual's immunization history. It is typically administered as an intramuscular injection or intravenously under medical supervision.
• The dosage is determined based on the weight of the individual and the estimated tetanus toxin dose.
• Tetanus Antitoxin is often used in combination with tetanus toxoid vaccination to provide both immediate and long-term protection.

Adverse reactions to Tetanus Antitoxin are rare but may include:

• Hypersensitivity reactions, such as rash, itching, or swelling
• Anaphylaxis (severe allergic reaction)
• Fever
• Nausea or vomiting
• Headache
• Dizziness or lightheadedness

Rash

Fever

Nausea

Headache

• Tetanus Antitoxin should be administered under the supervision of a healthcare professional experienced in the management of tetanus infection and the administration of immunoglobulins.
• Prior to administration, a careful evaluation of the individual's immunization history, tetanus risk factors, and potential hypersensitivity reactions should be conducted.
• Tetanus Antitoxin may contain trace amounts of human plasma proteins and may carry a risk of transmitting infectious agents. Standard precautions for the handling and administration of blood-derived products should be followed.